查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1494855

到 2030 年體外診斷實驗室自動化市場預測：按產品、設備、技術、應用、最終用戶和地區進行的全球分析

Lab Automation For In-Vitro Diagnostic Market Forecasts to 2030 - Global Analysis By Product, Equipment, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據Stratistics MRC的數據，2024年全球體外診斷實驗室自動化市場規模為1,315.9億美元，預計2030年將達到1,930.9億美元，複合年成長率為6.60%。

體外診斷實驗室自動化將徹底改變醫學實驗室的業務，透過最佳化工作流程來提高生產力。樣品製備、分析和資料管理等任務將自動化，結合先進的機器人、軟體和設備，以減少人為錯誤並提高吞吐量。借助這項技術，患者可以透過快速、準確的檢測，更快地得到診斷並決定治療方案。

根據美國臨床化學協會 (AACC) 的說法，實驗室自動化透過提高效率、減少錯誤並最終改善患者治療結果，在現代醫療保健中發揮重要作用。

對高性能評估的需求不斷增加

臨床診斷、基因組學、藥物發現和其他領域對高性能篩檢(HTS) 技術的應用正在不斷成長。 HTS 可用於快速篩檢大型化合物庫，以在藥物發現過程中尋找潛在的候選藥物。此外，次世代定序(NGS) 等 HTS 技術也有助於分析大量基因組資料，以用於基因組學領域的癌症基因組分析和個人化醫療等應用。

初始資本支出太多

實施實驗室自動化系統需要在人力資源、軟體、硬體和基礎設施方面進行大量前期投資。對於實驗室，尤其是預算緊張的小型實驗室來說，機器人系統、液體處理工作站和整合實驗室資訊管理系統 (LIMS) 等自動化平台的高成本可能會成為經濟負擔。此外，軟體更新、校準和維護的持續成本進一步增加了總擁有成本，這可能會阻礙注重預算的公司採用該技術。

擴大照護現場(POCT)

照護現場檢測 (POCT) 正在廣泛應用於各種醫療機構，包括診所、藥房、醫院和社區設施。這是由對分散測試解決方案和快速診斷服務不斷成長的需求所推動的。此外，透過實現現場測試、即時結果交付和快速臨床干預，POCT 設備、手持式分析儀、可攜式診斷設備和基於智慧型手機的應用程式可以改善患者的結果，從而實現及時診斷和醫療保健結果。

市場飽和，競爭激烈

在競爭激烈的體外診斷實驗室自動化市場中，許多全球公司、專業製造商和新興企業提供了廣泛的自動化解決方案和診斷測定。市場飽和，尤其是與激烈的價格競爭和自動化平台的商品化相結合，將對行業現有企業的利潤和收益成長帶來下行壓力。此外，替代產品、顛覆性技術和新競爭對手的興起增加了現有企業的壓力，導致價格競爭、市場佔有率下降和​​市場整合。

COVID-19 的影響：

體外診斷實驗室自動化市場受到 COVID-19 大流行的重大影響，機會與挑戰並存。儘管由於供應鏈中斷、製造延誤和醫療設施暫時關閉，疫情最初減緩了市場成長，但它加速了自動化技術的採用，以滿足診斷測試需求的激增。此外，實驗室自動化解決方案對於支援大流行應對工作以及透過提高檢測能力、最佳化樣本處理和縮短 COVID-19 檢測的交付時間來實現經濟的安全重新開放至關重要。

試劑和套件部分預計將在預測期內成為最大的部分

在體外診斷實驗室自動化市場中，試劑和套件通常佔據最大的市場佔有率。這些必要的元素包括廣泛的材料，例如診斷測試過程中使用的生物化學、抗體和探針。試劑和套件是許多測試的核心，從簡單的血液分析到複雜的分子診斷。此外，它的普遍存在是由於對準確有效的測試方法的持續需求以及它在各種診斷應用中的必要性。

液體處理機領域預計在預測期內複合年成長率最高

在體外診斷實驗室自動化市場中，自動液體處理機通常表現出最高的複合年成長率。自動化液體處理器簡化了將試劑和樣品等液體準確分配到不同容器、板和管中的過程。借助這項技術，實驗室工作流程變得更有效率、準確和高效。此外，對更快、標準化診斷流程的需求不斷成長，以及減少實驗室業務中的錯誤和提高可重複性的需求正在推動自動化液體處理系統的廣泛採用。

比最大的地區

體外診斷實驗室自動化市場由北美主導。該地區較早採用最尖端科技，在研發方面投入大量資金，並擁有先進的醫療基礎設施。市場領先的參與企業、支持性的政府政策以及對醫學研究的資助都有助於北美在該行業的主導地位。此外，由於人口老化和慢性病的高盛行率，對有效和準確的診斷解決方案的需求不斷增加。

複合年成長率最高的地區：

體外診斷實驗室自動化市場預計將以亞太地區最高的複合年成長率成長。這種快速成長是由多種因素推動的，包括醫療成本上升、醫療基礎設施的改善以及對先進診斷技術的日益重視。由於人口老化和慢性病盛行率上升，對有效、準確的診斷工具的需求不斷增加。此外，該地區還受益於大量公共和私人健康投資以及旨在實現檢測服務現代化的政府支援計劃。

免費客製化服務：

訂閱此報告的客戶可以利用以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與企業的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計/預測/複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 按產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行概述

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二次研究資訊來源
    • 先決條件

第3章市場趨勢分析

  • 介紹
  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 技術分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19 的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第 5 章：全球體外診斷實驗室自動化市場：按產品

  • 介紹
  • 試劑和套件
  • 裝置
  • 資料管理軟體
  • 其他

第 6 章：全球體外診斷實驗室自動化市場：依設備分類

  • 介紹
  • 自動板材處理機
  • 自動液體處理機
  • 機械臂
  • 自動倉儲系統
  • 分析儀
  • 其他

第 7 章：全球體外診斷實驗室自動化市場：依技術分類

  • 介紹
  • 免疫檢測/免疫化學
  • 臨床化學
  • 血液學
  • 分子診斷
  • 微生物學
  • 凝血和止血
  • 尿液檢查
  • 其他

第8章全球體外診斷實驗室自動化市場：依應用分類

  • 介紹
  • 感染疾病
  • 糖尿病
  • 藥物測試/藥物基因組學
  • 自體免疫疾病
  • 腫瘤學
  • 心臟病學
  • HIV/AIDS
  • 腎臟病學
  • 其他

第 9 章：全球體外診斷實驗室自動化市場：依最終使用者分類

  • 介紹
  • 醫院檢查室
  • 照護現場檢測中心
  • 學術機構
  • 臨床檢驗室
  • 病人
  • 其他

第 10 章：全球體外診斷實驗室自動化市場：按地區

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東/非洲

第11章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第12章 公司概況

  • F. Hoffmann-La Roche Ltd
  • Becton, Dickinson and Company
  • Cognex Corporation
  • Quidel Corporation
  • Abbott Laboratories
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Chembio Diagnostics, Inc
  • Bio-Rad Laboratories, Inc.
  • Surmodics, Inc.
  • Danaher Corporation
  • Tecan Group Ltd
  • Sysmex Corporation
  • Agilent Technologies Inc.
  • PerkinElmer Inc.
Product Code: SMRC26374

According to Stratistics MRC, the Global Lab Automation for In-Vitro Diagnostic Market is accounted for $131.59 billion in 2024 and is expected to reach $193.09 billion by 2030 growing at a CAGR of 6.60% during the forecast period. Medical laboratory operations are completely transformed by lab automation for in-vitro diagnostics, which increases productivity by optimizing workflows. Tasks like sample preparation, analysis, and data management are automated, lowering human error and boosting throughput by combining sophisticated robotics, software, and instrumentation. With the help of this technology, patients can receive a diagnosis and make treatment decisions more quickly thanks to rapid and accurate testing.

According to the American Association for Clinical Chemistry (AACC), laboratory automation plays a crucial role in modern healthcare by improving efficiency, reducing errors, and ultimately enhancing patient care outcomes.

Market Dynamics:

Driver:

Growing requirement for high-throughput evaluation

Clinical diagnostics, genomics, drug discovery, and other fields are finding increasing applications for high-throughput screening (HTS) techniques. With HTS, a large compound library can be quickly screened to find possible drug candidates in the drug discovery process. Moreover, the analysis of massive genomic data for uses like cancer genomics and personalized medicine is similarly made easier in the field of genomics by HTS technologies like next-generation sequencing (NGS).

Restraint:

Excessive initial capital outlay

Lab automation system implementation necessitates a large upfront investment in personnel training, software, hardware, and infrastructure. For laboratories, especially smaller ones with tighter budgets, the high cost of automation platforms such as robotic systems, liquid handling workstations, and integrated laboratory information management systems (LIMS) can be a financial burden. Furthermore, the total cost of ownership is further increased by continuing costs for software updates, calibration, and maintenance, which may discourage adoption among budget-conscious businesses.

Opportunity:

Point-of-care testing (POCT) expansion

Point-of-care testing (POCT) is becoming more widely used in a variety of healthcare settings, such as clinics, pharmacies, hospitals, and community-based facilities. This is due to the growing demand for decentralized testing solutions and quick diagnostic services. Moreover, by enabling on-site testing, real-time result delivery, and prompt clinical intervention, POCT devices, handheld analyzers, portable diagnostic instruments, and smart phone-based applications improve patient access to timely diagnosis and healthcare outcomes.

Threat:

Market Saturation and vigorous rivalry

A wide range of automation solutions and diagnostic assays are offered by a number of global players, specialized manufacturers, and start-ups in the fiercely competitive lab automation for in-vitro diagnostics market. Market saturation puts downward pressure on profit margins and revenue growth for industry incumbents, especially when combined with fierce price competition and the commoditization of automation platforms. Additionally, the rise of substitute products, disruptive technologies, and new competitors increases the pressure on existing ones, causing price wars, market share erosion, and market consolidation.

Covid-19 Impact:

The market for lab automation for in-vitro diagnostics has been significantly impacted by the COVID-19 pandemic, which has brought about both opportunities and challenges. Although the pandemic slowed market growth initially due to supply chain disruptions, manufacturing delays, and healthcare facilities temporarily closing, it also accelerated the adoption of automation technologies to meet the spike in demand for diagnostic testing. Furthermore, solutions for laboratory automation were essential in helping to support pandemic response efforts and enable the safe reopening of economies by increasing testing capacity, optimizing sample processing, and shortening turnaround times for COVID-19 testing.

The Reagents and Kits segment is expected to be the largest during the forecast period

Reagents and kits usually have the largest market share in the lab automation for in-vitro diagnostics market. These necessary elements include a broad range of materials, such as biochemical, antibodies, and probes that are utilized in diagnostic testing procedures. From simple blood analyses to intricate molecular diagnostics, reagents and kits are the cornerstone of many tests. Moreover, their ubiquity is attributed to their necessity in a variety of diagnostic applications as well as the ongoing need for precise and effective testing methods.

The Automated Liquid Handler segment is expected to have the highest CAGR during the forecast period

In the lab automation for in vitro diagnostic market, the automated liquid handler usually exhibits the highest CAGR. With the least amount of human involvement, automated liquid handlers simplify the process of precisely dispensing liquids-such as reagents and samples-into different containers, plates, or tubes. With the help of this technology, laboratory workflows can be made much more efficient, accurate, and productive. Additionally, the growing need for quicker and more standardized diagnostic processes, as well as the need to lower errors and enhance reproducibility in laboratory operations, are what are driving the increasing adoption of automated liquid handling systems.

Region with largest share:

The market for lab automation for in-vitro diagnostics is dominated by North America. The region's early adoption of cutting-edge technologies, substantial investment in research and development, and sophisticated healthcare infrastructure are all credited with its dominance. Leading market participants, supportive government policies, and financing for medical research all contribute to North America's dominant position in the industry. Furthermore, the need for effective and precise diagnostic solutions is fueled by the aging population and the high prevalence of chronic diseases.

Region with highest CAGR:

The lab automation for in-vitro diagnostic market is anticipated to grow at the highest CAGR in the Asia-Pacific region. Numerous factors, such as rising healthcare costs, growing healthcare infrastructure, and a growing emphasis on advanced diagnostic technologies, are responsible for this rapid growth. The need for effective and precise diagnostic tools is fueled by the aging population and the rising incidence of chronic diseases. Additionally, the area also gains from significant public and private healthcare investments, as well as from supportive government programs targeted at modernizing laboratory services.

Key players in the market

Some of the key players in Lab Automation For In-Vitro Diagnostic market include F. Hoffmann-La Roche Ltd, Becton, Dickinson and Company, Cognex Corporation, Quidel Corporation, Abbott Laboratories, Siemens Healthineers AG, Thermo Fisher Scientific Inc., Chembio Diagnostics, Inc, Bio-Rad Laboratories, Inc., Surmodics, Inc., Danaher Corporation, Tecan Group Ltd, Sysmex Corporation, Agilent Technologies Inc. and PerkinElmer Inc.

Key Developments:

In January 2024, BD (Becton, Dickinson and Company), a leading global medical technology company, announced a collaboration agreement with Hamilton, a leading global manufacturer of laboratory automation technology, to develop automated applications together with robotics-compatible reagent kits to enable greater standardization and reduced human error when conducting large-scale single-cell multiomics experiments.

In December 2023, Roche announced the entry into a definitive merger agreement to acquire Carmot Therapeutics, Inc. ("Carmot"), a privately owned US company based in Berkeley, California. Carmot's R&D portfolio includes clinical stage subcutaneous and oral incretins with best-in-class potential to treat obesity in patients with and without diabetes, as well as a number of preclinical programs.

In August 2023, Cognex Corporation, a leader in industrial machine vision, announced it has agreed to acquire Moritex Corporation (Moritex) from Trustar Capital, a private equity affiliate of CITIC Capital Holdings Limited, for ¥40 billion (approximately $275 million), in an all-cash transaction. Moritex is a leading global provider of optics components with a strong presence in Japan.

Products Covered:

  • Reagents and Kits
  • Instruments
  • Data Management Software
  • Other Products

Equipments Covered:

  • Automated Plate Handler
  • Automated Liquid Handler
  • Robotic Arm
  • Automated Storage and Retrieval System
  • Analyzer
  • Other Equipments

Technologies Covered:

  • Immunoassay/ Immunochemistry
  • Clinical Chemistry
  • Hematology
  • Molecular Diagnostics
  • Microbiology
  • Coagulation And Hemostasis
  • Urinalysis
  • Other Technologies

Applications Covered:

  • Infectious Diseases
  • Diabetes
  • Drug Testing/ Pharmacogenomics
  • Autoimmune Diseases
  • Oncology
  • Cardiology
  • HIV/AIDS
  • Nephrology
  • Other Applications

End Users Covered:

  • Hospital Laboratories
  • Point-Of-Care Testing Centers
  • Academic Institutes
  • Clinical Laboratories
  • Patients
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Lab Automation For In-Vitro Diagnostic Market, By Product

  • 5.1 Introduction
  • 5.2 Reagents and Kits
  • 5.3 Instruments
  • 5.4 Data Management Software
  • 5.5 Other Products

6 Global Lab Automation For In-Vitro Diagnostic Market, By Equipment

  • 6.1 Introduction
  • 6.2 Automated Plate Handler
  • 6.3 Automated Liquid Handler
  • 6.4 Robotic Arm
  • 6.5 Automated Storage and Retrieval System
  • 6.6 Analyzer
  • 6.7 Other Equipments

7 Global Lab Automation For In-Vitro Diagnostic Market, By Technology

  • 7.1 Introduction
  • 7.2 Immunoassay/ Immunochemistry
  • 7.3 Clinical Chemistry
  • 7.4 Hematology
  • 7.5 Molecular Diagnostics
  • 7.6 Microbiology
  • 7.7 Coagulation And Hemostasis
  • 7.8 Urinalysis
  • 7.9 Other Technologies

8 Global Lab Automation For In-Vitro Diagnostic Market, By Application

  • 8.1 Introduction
  • 8.2 Infectious Diseases
  • 8.3 Diabetes
  • 8.4 Drug Testing/ Pharmacogenomics
  • 8.5 Autoimmune Diseases
  • 8.6 Oncology
  • 8.7 Cardiology
  • 8.8 HIV/AIDS
  • 8.9 Nephrology
  • 8.10 Other Applications

9 Global Lab Automation For In-Vitro Diagnostic Market, By End User

  • 9.1 Introduction
  • 9.2 Hospital Laboratories
  • 9.3 Point-Of-Care Testing Centers
  • 9.4 Academic Institutes
  • 9.5 Clinical Laboratories
  • 9.6 Patients
  • 9.7 Other End Users

10 Global Lab Automation For In-Vitro Diagnostic Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 F. Hoffmann-La Roche Ltd
  • 12.2 Becton, Dickinson and Company
  • 12.3 Cognex Corporation
  • 12.4 Quidel Corporation
  • 12.5 Abbott Laboratories
  • 12.6 Siemens Healthineers AG
  • 12.7 Thermo Fisher Scientific Inc.
  • 12.8 Chembio Diagnostics, Inc
  • 12.9 Bio-Rad Laboratories, Inc.
  • 12.10 Surmodics, Inc.
  • 12.11 Danaher Corporation
  • 12.12 Tecan Group Ltd
  • 12.13 Sysmex Corporation
  • 12.14 Agilent Technologies Inc.
  • 12.15 PerkinElmer Inc.

List of Tables

  • Table 1 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Product (2022-2030) ($MN)
  • Table 3 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Reagents and Kits (2022-2030) ($MN)
  • Table 4 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Instruments (2022-2030) ($MN)
  • Table 5 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Data Management Software (2022-2030) ($MN)
  • Table 6 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Other Products (2022-2030) ($MN)
  • Table 7 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Equipment (2022-2030) ($MN)
  • Table 8 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Automated Plate Handler (2022-2030) ($MN)
  • Table 9 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Automated Liquid Handler (2022-2030) ($MN)
  • Table 10 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Robotic Arm (2022-2030) ($MN)
  • Table 11 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Automated Storage and Retrieval System (2022-2030) ($MN)
  • Table 12 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Analyzer (2022-2030) ($MN)
  • Table 13 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Other Equipments (2022-2030) ($MN)
  • Table 14 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Technology (2022-2030) ($MN)
  • Table 15 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Immunoassay/ Immunochemistry (2022-2030) ($MN)
  • Table 16 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Clinical Chemistry (2022-2030) ($MN)
  • Table 17 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Hematology (2022-2030) ($MN)
  • Table 18 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Molecular Diagnostics (2022-2030) ($MN)
  • Table 19 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Microbiology (2022-2030) ($MN)
  • Table 20 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Coagulation And Hemostasis (2022-2030) ($MN)
  • Table 21 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Urinalysis (2022-2030) ($MN)
  • Table 22 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Other Technologies (2022-2030) ($MN)
  • Table 23 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Application (2022-2030) ($MN)
  • Table 24 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Infectious Diseases (2022-2030) ($MN)
  • Table 25 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Diabetes (2022-2030) ($MN)
  • Table 26 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Drug Testing/ Pharmacogenomics (2022-2030) ($MN)
  • Table 27 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Autoimmune Diseases (2022-2030) ($MN)
  • Table 28 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Oncology (2022-2030) ($MN)
  • Table 29 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Cardiology (2022-2030) ($MN)
  • Table 30 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By HIV/AIDS (2022-2030) ($MN)
  • Table 31 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Nephrology (2022-2030) ($MN)
  • Table 32 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 33 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By End User (2022-2030) ($MN)
  • Table 34 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Hospital Laboratories (2022-2030) ($MN)
  • Table 35 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Point-Of-Care Testing Centers (2022-2030) ($MN)
  • Table 36 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Academic Institutes (2022-2030) ($MN)
  • Table 37 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Clinical Laboratories (2022-2030) ($MN)
  • Table 38 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Patients (2022-2030) ($MN)
  • Table 39 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.